Hereditary peripheral neuropathies are common human genetic conditions. These clinically and genetically heterogeneous disorders produce progressive deterioration of the peripheral nerves with secondary muscle wasting and weakness in a distal distribution. The application of molecular genetic techniques to this group of disorders has resulted in a more comprehensive understanding of peripheral nerve biology that has important clinical implications. This proposal focuses on the identification of genes, molecular genetic bases, and pathogenic mechanisms regarding the inherited peripheral neuropathy Charcot- Marie-Tooth disease and related disorders. Human genetic and genomic approaches, informatics applications to genome databases, expression profiling coupled with mapping of peripheral nerve- specific genes, comparative genome studies between human and nonhuman primates, and molecular studies of a large cohort of patients manifesting peripheral neuropathies will be utilized to extend our understanding of the human peripheral nerve neurobiology. The major hypotheses to be tested are: (i) the identification of the genes involved in rare forms of familial neuropathy will provide insights into peripheral nerve structure/function and maintenance; (ii) genes that are downstream targets of the transcription factor EGR2 are important candidates for inherited peripheral nerve disease; (iii) structural features of the human genome may result in susceptibility to constitutional DNA rearrangements associated with disease. To address these hypotheses six specific aims are proposed. These include a continuation of the collection of rare neuropathy patients and utilizing DNA samples for such patients to identify additional """"""""peripheral nerve disease genes"""""""" by focusing on the genes for proteins that interact with periaxin and genes which are downstream from the peripheral nerve developmental transcription factor EGR2. In addition, a novel general strategy is proposed to identify peripheral nerve- specific genes utilizing bioinformatics procedures and information from the Human Genome Project to establish both positional candidate neuropathy disease genes and a microarray for expression profiling of the peripheral nervous system. Finally, based on some of our previous studies, which have enabled the identification of structural features of the human genome important to the DNA rearrangements responsible for peripheral neuropathy, we will examine additional features which may result in susceptibility to DNA rearrangement as well as examine these genome architectural features during primate species to gain insights into the recent evolution of mammalian genome and its implications for genomic disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
2R01NS027042-13
Application #
6434754
Study Section
Special Emphasis Panel (ZRG1-BDCN-3 (01))
Program Officer
Nichols, Paul L
Project Start
1990-01-01
Project End
2005-12-31
Budget Start
2002-01-01
Budget End
2002-12-31
Support Year
13
Fiscal Year
2002
Total Cost
$512,744
Indirect Cost
Name
Baylor College of Medicine
Department
Genetics
Type
Schools of Medicine
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Lupski, James R; Belmont, John W; Boerwinkle, Eric et al. (2011) Clan genomics and the complex architecture of human disease. Cell 147:32-43
Inoue, Ken; Ohyama, Tomoko; Sakuragi, Yosuke et al. (2007) Translation of SOX10 3'untranslated region causes a complex severe neurocristopathy by generation of a deleterious functional domain. Hum Mol Genet 16:3037-46
Khajavi, Mehrdad; Shiga, Kensuke; Wiszniewski, Wojciech et al. (2007) Oral curcumin mitigates the clinical and neuropathologic phenotype of the Trembler-J mouse: a potential therapy for inherited neuropathy. Am J Hum Genet 81:438-53
Khajavi, Mehrdad; Inoue, Ken; Lupski, James R (2006) Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease. Eur J Hum Genet 14:1074-81
Lee, Jennifer A; Inoue, Ken; Cheung, Sau W et al. (2006) Role of genomic architecture in PLP1 duplication causing Pelizaeus-Merzbacher disease. Hum Mol Genet 15:2250-65
Szigeti, Kinga; Nelis, Eva; Lupski, James R (2006) Molecular diagnostics of Charcot-Marie-Tooth disease and related peripheral neuropathies. Neuromolecular Med 8:243-54
Lee, Jennifer A; Madrid, Ricardo E; Sperle, Karen et al. (2006) Spastic paraplegia type 2 associated with axonal neuropathy and apparent PLP1 position effect. Ann Neurol 59:398-403
Shy, Michael E; Scavina, Mena T; Clark, Alisa et al. (2006) T118M PMP22 mutation causes partial loss of function and HNPP-like neuropathy. Ann Neurol 59:358-64
Saifi, Gulam Mustafa; Szigeti, Kinga; Wiszniewski, Wojciech et al. (2005) SIMPLE mutations in Charcot-Marie-Tooth disease and the potential role of its protein product in protein degradation. Hum Mutat 25:372-83
Khajavi, Mehrdad; Inoue, Ken; Wiszniewski, Wojciech et al. (2005) Curcumin treatment abrogates endoplasmic reticulum retention and aggregation-induced apoptosis associated with neuropathy-causing myelin protein zero-truncating mutants. Am J Hum Genet 77:841-50

Showing the most recent 10 out of 63 publications